Introduction

This page provides a comprehensive analysis of the known insider trading history of Benjamin T Dake. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Benjamin T Dake has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:AVTE / Aerovate Therapeutics, Inc. SEE REMARKS 14,252
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Benjamin T Dake. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Benjamin T Dake as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-08-02 2024-08-01 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise 1,507 14,252 11.82 1.74 2,622 24,798
2024-08-02 2024-07-31 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise 11,454 12,745 887.22 1.74 19,930 22,176
2024-04-19 2024-04-17 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -68 1,291 -5.00 23.97 -1,630 30,945
2024-04-19 2024-04-17 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -338 1,359 -19.92 23.17 -7,831 31,488
2024-04-19 2024-04-17 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -6,447 1,697 -79.16 22.32 -143,865 37,869
2024-04-19 2024-04-17 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 6,853 8,144 530.83 2.14 14,665 17,428
2024-04-03 2024-04-01 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3,325 1,291 -72.03 31.97 -106,317 41,280
2024-04-03 2024-04-01 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 3,325 4,616 257.55 10.61 35,278 48,976
2024-03-28 2024-03-27 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -11,068 1,291 -89.55 27.97 -309,519 36,103
2024-03-28 2024-03-27 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 11,068 12,359 857.32 10.61 117,431 131,129
2024-03-27 2024-03-25 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3,432 1,291 -72.67 28.01 -96,119 36,157
2024-03-27 2024-03-25 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 3,432 4,723 265.84 10.61 36,414 50,111
2024-03-20 2024-03-18 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -7,581 1,291 -85.45 26.48 -200,764 34,189
2024-03-20 2024-03-18 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -27,476 8,872 -75.59 25.74 -707,282 228,381
2024-03-20 2024-03-18 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 14,500 36,348 66.37 10.61 153,845 385,652
2024-03-20 2024-03-18 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 20,557 21,848 1,592.33 2.14 43,992 46,755
2023-12-07 2023-12-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -10,283 1,291 -88.85 16.11 -165,628 20,794
2023-12-07 2023-12-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7,872 11,574 212.64 2.14 16,846 24,768
2023-12-07 2023-12-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2,411 3,702 186.75 1.74 4,195 6,441
2023-11-29 2023-11-27 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -12,517 1,291 -90.65 16.24 -203,237 20,962
2023-11-29 2023-11-27 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 10,104 13,808 272.79 2.14 21,623 29,549
2023-11-29 2023-11-27 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2,413 3,704 186.91 1.74 4,199 6,445
2023-11-27 2023-11-24 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -70 1,291 -5.14 16.07 -1,125 20,741
2023-11-27 2023-11-24 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -4,920 1,361 -78.33 15.74 -77,423 21,417
2023-11-27 2023-11-24 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 4,990 6,281 386.52 2.14 10,679 13,441
2023-11-27 2023-11-22 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -9,382 1,291 -87.90 15.17 -142,359 19,589
2023-11-27 2023-11-22 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 6,970 10,673 188.23 2.14 14,916 22,840
2023-11-27 2023-11-22 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2,412 3,703 186.83 1.74 4,197 6,443
2023-09-08 2023-09-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -30 1,291 -2.27 15.01 -450 19,378
2023-09-08 2023-09-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 30 1,321 2.32 2.14 64 2,827
2023-09-08 2023-09-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3,931 1,291 -75.28 15.06 -59,187 19,438
2023-09-08 2023-09-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 1,518 5,222 40.98 2.14 3,249 11,175
2023-09-08 2023-09-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2,413 3,704 186.91 1.74 4,199 6,445
2023-08-09 2023-08-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -541 1,291 -29.53 16.25 -8,789 20,972
2023-08-09 2023-08-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -9,742 1,832 -84.17 15.48 -150,792 28,357
2023-08-09 2023-08-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7,871 11,574 212.56 2.14 16,844 24,768
2023-08-09 2023-08-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2,412 3,703 186.83 1.74 4,197 6,443
2023-07-07 2023-07-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -10,283 1,291 -88.85 16.66 -171,284 21,504
2023-07-07 2023-07-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7,871 11,574 212.56 2.14 16,844 24,768
2023-07-07 2023-07-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2,412 3,703 186.83 1.74 4,197 6,443
2023-06-08 2023-06-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -15 1,291 -1.15 16.98 -255 21,915
2023-06-08 2023-06-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -10,268 1,306 -88.72 16.28 -167,161 21,261
2023-06-08 2023-06-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7,871 11,574 212.56 2.14 16,844 24,768
2023-06-08 2023-06-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2,412 3,703 186.83 1.74 4,197 6,443
2023-05-09 2023-05-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1,599 1,291 -55.33 22.74 -36,355 29,352
2023-05-09 2023-05-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -8,685 2,890 -75.03 21.62 -187,805 62,494
2023-05-09 2023-05-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7,871 11,575 212.50 2.14 16,844 24,770
2023-05-09 2023-05-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2,413 3,704 186.91 1.74 4,199 6,445
2023-04-07 2023-04-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -10,283 0 -100.00 18.17 -186,829
2023-04-07 2023-04-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7,871 10,283 326.33 2.14 16,844 22,006
2023-04-07 2023-04-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2,412 2,412 1.74 4,197 4,197
2023-03-08 2023-03-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -215 0 -100.00 24.50 -5,267
2023-03-08 2023-03-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -10,067 215 -97.91 23.71 -238,687 5,098
2023-03-08 2023-03-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7,870 10,282 326.29 2.14 16,842 22,003
2023-03-08 2023-03-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2,412 2,412 1.74 4,197 4,197
2023-02-08 2023-02-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1,426 0 -100.00 25.02 -35,679
2023-02-08 2023-02-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -8,858 1,426 -86.13 24.52 -217,203 34,966
2023-02-08 2023-02-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7,872 10,284 326.37 2.14 16,846 22,008
2023-02-08 2023-02-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2,412 2,412 1.74 4,197 4,197
2023-01-09 2023-01-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -2,792 0 -100.00 26.95 -75,254
2023-01-09 2023-01-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -7,492 2,792 -72.85 25.62 -191,949 71,532
2023-01-09 2023-01-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7,871 10,284 326.19 2.14 16,844 22,008
2023-01-09 2023-01-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2,413 2,413 1.74 4,199 4,199
2022-12-14 2022-12-12 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -907 0 -100.00 30.26 -27,443
2022-12-14 2022-12-12 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1,132 907 -55.52 28.83 -32,632 26,146
2022-12-14 2022-12-12 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -20 2,039 -0.97 25.82 -516 52,647
2022-12-14 2022-12-12 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2,059 2,059 2.14 4,406 4,406
2022-12-12 2022-12-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -394 0 -100.00 25.03 -9,861
2022-12-12 2022-12-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 394 394 2.14 843 843
2022-12-12 2022-12-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3,178 0 -100.00 24.08 -76,533
2022-12-12 2022-12-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3,199 3,178 -50.16 22.56 -72,178 71,705
2022-12-12 2022-12-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -2,695 6,377 -29.71 21.63 -58,302 137,957
2022-12-12 2022-12-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -928 9,072 -9.28 20.94 -19,435 189,996
2022-12-12 2022-12-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 10,000 10,000 2.14 21,400 21,400
2022-12-08 2022-12-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -615 0 -100.00 18.29 -11,250
2022-12-08 2022-12-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -36,115 615 -98.33 17.80 -642,861 10,947
2022-12-08 2022-12-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1,259 36,730 -3.31 16.90 -21,275 620,678
2022-12-08 2022-12-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -2,011 37,989 -5.03 15.61 -31,386 592,906
2022-12-08 2022-12-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 37,588 40,000 1,558.37 2.14 80,438 85,600
2022-12-08 2022-12-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2,412 2,412 1.74 4,197 4,197
2022-11-14 2022-11-11 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -121 0 -100.00 22.20 -2,686
2022-11-14 2022-11-11 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1,625 121 -93.07 21.41 -34,796 2,591
2022-11-14 2022-11-11 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -4,452 1,746 -71.83 20.39 -90,754 35,592
2022-11-14 2022-11-11 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 6,198 6,198 2.14 13,264 13,264
2022-11-14 2022-11-10 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1,800 0 -100.00 20.10 -36,172
2022-11-14 2022-11-10 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 1,800 1,800 2.14 3,852 3,852
2022-11-14 2022-11-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -14,000 0 -100.00 17.91 -250,677
2022-11-14 2022-11-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 14,000 14,000 2.14 29,960 29,960
2022-11-09 2022-11-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -8,373 0 -100.00 18.09 -151,458
2022-11-09 2022-11-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 8,373 8,373 2.14 17,918 17,918
2022-11-09 2022-11-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1,660 0 -100.00 20.24 -33,594
2022-11-09 2022-11-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1,486 1,660 -47.23 19.57 -29,081 32,486
2022-11-09 2022-11-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3,359 3,146 -51.64 18.58 -62,399 58,443
2022-11-09 2022-11-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -11,122 6,505 -63.10 17.79 -197,819 115,700
2022-11-09 2022-11-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 15,214 17,627 630.50 2.14 32,558 37,722
2022-11-09 2022-11-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2,413 2,413 1.74 4,199 4,199
2022-10-20 2022-10-18 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -5,705 0 -100.00 21.08 -120,287
2022-10-20 2022-10-18 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 5,705 5,705 2.14 12,209 12,209
2022-10-18 2022-10-17 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -4,185 0 -100.00 20.16 -84,380
2022-10-18 2022-10-17 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 4,185 4,185 2.14 8,956 8,956
2022-10-18 2022-10-14 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -110 0 -100.00 20.05 -2,206
2022-10-18 2022-10-14 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 110 110 2.14 235 235
2022-10-12 2022-10-10 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1,430 0 -100.00 17.26 -24,689
2022-10-12 2022-10-10 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3,524 1,430 -71.13 16.74 -58,992 23,938
2022-10-12 2022-10-10 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 4,954 4,954 2.14 10,602 10,602
2022-10-11 2022-10-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1,757 0 -100.00 16.41 -28,828
2022-10-11 2022-10-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -8,763 1,757 -83.30 15.93 -139,631 27,996
2022-10-11 2022-10-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 10,520 10,520 2.14 22,513 22,513
2022-10-11 2022-10-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -948 0 -100.00 17.31 -16,411
2022-10-11 2022-10-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -882 948 -48.20 16.54 -14,589 15,680
2022-10-11 2022-10-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -11,210 1,830 -85.97 15.64 -175,345 28,624
2022-10-11 2022-10-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 10,629 13,040 440.85 2.14 22,746 27,906
2022-10-11 2022-10-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 2,411 2,411 1.74 4,195 4,195
2022-09-14 2022-09-12 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -272 0 -100.00 18.77 -5,105
2022-09-14 2022-09-12 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1,976 272 -87.90 18.26 -36,087 4,967
2022-09-14 2022-09-12 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -5,272 2,248 -70.11 16.90 -89,115 37,999
2022-09-14 2022-09-12 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 7,520 7,520 2.14 16,093 16,093
2022-09-12 2022-09-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -176 0 -100.00 18.54 -3,262
2022-09-12 2022-09-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -4,544 176 -96.27 17.50 -79,540 3,081
2022-09-12 2022-09-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 4,462 4,720 1,729.46 2.14 9,549 10,101
2022-09-12 2022-09-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 258 258 1.74 449 449
2022-09-12 2022-09-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -629 0 -100.00 18.42 -11,588
2022-09-12 2022-09-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -2,491 629 -79.84 18.14 -45,193 11,412
2022-09-12 2022-09-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 3,120 3,120 1.74 5,429 5,429
2022-09-08 2022-09-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3,658 0 -100.00 18.42 -67,386
2022-09-08 2022-09-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -5 3,658 -0.12 18.12 -83 66,270
2022-09-08 2022-09-07 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 8,220 8,220 1.74 14,303 14,303
2022-09-08 2022-09-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -606 0 -100.00 19.78 -11,984
2022-09-08 2022-09-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -4,138 606 -87.23 18.98 -78,546 11,503
2022-09-08 2022-09-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -4,422 4,744 -48.24 17.94 -79,345 85,123
2022-09-08 2022-09-06 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 9,166 9,166 1.74 15,949 15,949
2022-08-18 2022-08-16 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3,451 0 -100.00 24.10 -83,174
2022-08-18 2022-08-16 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -7,074 3,451 -67.21 23.29 -164,724 80,360
2022-08-18 2022-08-16 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -10,475 10,525 -49.88 22.44 -235,034 236,156
2022-08-18 2022-08-16 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 21,000 21,000 1.74 36,540 36,540
2022-08-12 2022-08-11 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -79 0 -100.00 24.55 -1,939
2022-08-12 2022-08-11 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -1,268 79 -94.14 23.89 -30,292 1,887
2022-08-12 2022-08-11 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 1,347 1,347 1.74 2,344 2,344
2022-08-12 2022-08-10 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -780 0 -100.00 24.48 -19,096
2022-08-12 2022-08-10 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -11,940 780 -93.87 24.06 -287,270 18,766
2022-08-12 2022-08-10 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 12,720 12,720 1.74 22,133 22,133
2022-08-10 2022-08-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -2,791 0 -100.00 24.52 -68,436
2022-08-10 2022-08-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -5,909 2,791 -67.92 23.84 -140,889 66,546
2022-08-10 2022-08-09 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 8,700 8,700 1.74 15,138 15,138
2022-08-10 2022-08-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -2,954 0 -100.00 24.94 -73,678
2022-08-10 2022-08-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
S - Sale X -3,989 2,954 -57.45 24.39 -97,283 72,042
2022-08-10 2022-08-08 4 AVTE Aerovate Therapeutics, Inc.
Common Stock
M - Exercise X 6,943 6,943 1.74 12,081 12,081
2021-12-16 2021-12-14 4 AVTE Aerovate Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 58,000 58,000
2021-07-01 2021-06-29 4 AVTE Aerovate Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 180,800 180,800
2021-07-01 2021-04-02 4 AVTE Aerovate Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 328,921 328,921
2021-07-01 2021-04-02 4 AVTE Aerovate Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 48,882 48,882
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)